Clearstead Trust’s RXO RXO Stock Holding History

Clearstead Trust’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-90	Closed	-$1.39K	–	1438
2025 Q3	$1.39K	Hold	90	–	–	﹤0.01%	1117
2025 Q2	$1.42K	Buy	+90	New	+$1.36K	﹤0.01%	1049

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Clearstead Trust's RXO Position: Q4 2025 in Review

Clearstead Trust sold out of RXO (RXO) in Q4 2025, closing a stake of 90 shares — an estimated $1.39K sold.

Clearstead Trust first reported a position in RXO in Q2 2025 and held it in 2 quarters. The position peaked at $1.42K in Q2 2025. 269 funds tracked by Wall St. Rank hold RXO as of Q4 2025.

Clearstead Trust reported no remaining RXO position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 90 RXO shares in Q4 2025, an estimated $1.39K.
Clearstead Trust first reported a position in RXO in Q2 2025 and held it in 2 quarters.
Clearstead Trust's RXO position peaked at $1.42K in Q2 2025.
269 funds tracked by Wall St. Rank held RXO as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.